Seyed Mohammad Alavi
Overview
Explore the profile of Seyed Mohammad Alavi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Alavi S, Enayatrad M, Cheraghian B, Amoori N
Glob Epidemiol
. 2023 Aug;
6:100118.
PMID: 37637715
Objectives: Identifying the trend of diseases and its changes over time can be highly important in evaluating the extent and method of achieving strategies for controlling them, developing health indicators,...
12.
Abedi P, Afshari P, Ansari S, Alavi S, Dashtpayma S, Amiri H
Health Sci Rep
. 2023 Jul;
6(7):e1420.
PMID: 37492272
Background And Aims: Reinfection with the coronavirus disease 2019 (COVID-19) virus may be as serious as the first infection, exposing people to risks such as admission to hospital or even...
13.
Amoori N, Amini P, Cheraghian B, Alavi S
BMC Pulm Med
. 2023 Jun;
23(1):226.
PMID: 37365556
Background: Tuberculosis is known as one of the principal health problems, especially in developing countries. This study aimed to visualize, statistically model, and describe the weighted networks to investigate the...
14.
Afshari P, Alavi S, Abedi P, Beheshtinasab M, Dashtpayma S, Amiri H
Clin Exp Vaccine Res
. 2023 May;
12(2):127-133.
PMID: 37214142
Purpose: Around 70% of the Iranian population had received two doses of coronavirus disease 2019 (COVID-19) vaccines by the end of 2021. In this study, we evaluated the reasons for...
15.
Amoori N, Cheraghian B, Amini P, Alavi S
J Prev Med Public Health
. 2022 Oct;
55(5):485-491.
PMID: 36229911
Objectives: Tuberculosis (TB) is a major public health concern worldwide. Social contact patterns can affect the epidemiology and risk of airborne diseases such as TB. This study was designed to...
16.
Amiri H, Mohammadi M, Alavi S, Salmanzadeh S, Hematnia F, Azar M, et al.
BMC Public Health
. 2021 Dec;
21(1):2318.
PMID: 34949165
Background: Tuberculosis (TB) is one of the ten leading causes of death in infectious diseases and one of the ten leading causes of death in the world. For any TB...
17.
Shohan M, Nashibi R, Mahmoudian-Sani M, Abolnezhadian F, Ghafourian M, Alavi S, et al.
Eur J Pharmacol
. 2021 Dec;
914:174615.
PMID: 34863994
In this study, the therapeutic efficacy of quercetin in combination with remdesivir and favipiravir, were evaluated in severe hospitalized COVID-19 patients. Our main objective was to assess the ability of...
18.
Abolnezhadian F, Makvandi M, Alavi S, Azaran A, Jalilian S, Rashno M, et al.
Iran J Allergy Asthma Immunol
. 2021 Jan;
19(5):471-477.
PMID: 33463114
The emergence of a highly pathogenic virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) accounts for severe pneumonia throughout the world. More than 7 million world population have been...
19.
Salmanzadeh S, Karamian M, Alavi S, Nashibi R
J Family Med Prim Care
. 2020 Jul;
9(4):1958-1962.
PMID: 32670947
Introduction: Despite the great efforts to control tuberculosis (TB), the disease is still one of the major health challenges throughout the world. The basic treatment for TB is drug therapy....
20.
Moradi A, Alavi S, Salimi M, Nouhjah S, Abdolahi Shahvali E
Diabetes Metab Syndr
. 2019 Jul;
13(2):1255-1260.
PMID: 31336474
Objective: The present study aimed at evaluating the effectiveness of an educational intervention via mobile cells on foot care knowledge and foot care practices in patients with type 2 diabetes....